Topical Administration Of New Oligonucleotide Effectively Treats Corneal Neovascularization In Small Study

Thursday, May 14, 2009

Comments

Ocular Surgery News

Topical administration of a new oligonucleotide, the Gene Signal GS-101, is showing positive results in reducing corneal neovascularization without the hypoxic effects of anti-VEGF agents, according to a study carried out at the University Hospital of Valencia, Spain.

Full Story

Corneal and Refractive Diagnostics »

What are the manifestations of PHPV?
1. A retrolental plaque that contracts, thereby elongating the ciliary processes
2. A cataractous lens which may contain a lipoidal material
3. Microphthalmos (if not microphthalmic, question the diagnosis)
4. Progressive AC shallowing producing angle-closure glaucoma
5. Jumping Beans
... Check The Answer